<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">

<channel>
<title><![CDATA[Chugai Pharmaceutical: News Releases]]></title>
<link>https://www.chugai-pharm.co.jp/english/index.html</link>
<description><![CDATA[News Releases]]></description>
<category><![CDATA[News Releases]]></category>
<language>en-us</language>
<copyright><![CDATA[Copyright(C) Chugai Pharmacetical Co.,Ltd. All rights reserved.]]></copyright>
<lastBuildDate>Mon, 14 Sep 2026 15:30:00 +0900</lastBuildDate>

<item>
<title><![CDATA[Personnel Changes]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260914153000_1285.html</link>
<description></description>
<category></category>
<pubDate>Mon, 14 Sep 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260914153000_1285.html</guid>
</item>
<item>
<title><![CDATA[Roche Announces U.S. FDA Grants Priority Review for Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260910180000_1282.html</link>
<description></description>
<category></category>
<pubDate>Thu, 10 Sep 2026 18:00:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260910180000_1282.html</guid>
</item>
<item>
<title><![CDATA[Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World&rsquo;s Most Respected Scientific Honors - Recognized for the invention of a bispecific antibody that transformed treatment paradigm through an unconventional approach –]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260909210000_1283.html</link>
<description></description>
<category></category>
<pubDate>Wed, 09 Sep 2026 21:00:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260909210000_1283.html</guid>
</item>
<item>
<title><![CDATA[Research Achievement Related to Chugai-Originated Nemolizumab Receives the 11th JBDA Award for Drug Discovery]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260907153000_1284.html</link>
<description></description>
<category></category>
<pubDate>Mon, 07 Sep 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260907153000_1284.html</guid>
</item>
<item>
<title><![CDATA[Vamikibart Filed for Regulatory Approval in Japan for Uveitic Macular Edema Associated with Non-Infectious Uveitis]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260825153000_1281.html</link>
<description></description>
<category></category>
<pubDate>Tue, 25 Aug 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260825153000_1281.html</guid>
</item>
<item>
<title><![CDATA[Chugai and GSK Sign Exclusive License Agreement for Anti-Dengue Virus Antibody AID351]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260818113000_1263.html</link>
<description></description>
<category></category>
<pubDate>Tue, 18 Aug 2026 11:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260818113000_1263.html</guid>
</item>

</channel>
</rss>
